Paclitaxel-eluting stents for chronically occluded saphenous veingrafts (EOS) study

Journal of Interventional Cardiology

Volumn 23, Issue 1, 2010, Pages 40-45

  Jim, Man Hong ^a   Ho, Hee Hwa ^a   Ko, Ryan Lap Yan ^b   Siu, Chung Wah ^b   Yiu, Kai Hang ^b   Lau, Chu Pak ^b   Chow, Wing Hing ^a  

^a GRANTHAM HOSPITAL   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PACLITAXEL;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BYPASS SURGERY; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; SAPHENOUS VEIN GRAFT; SURVIVAL RATE; TREATMENT OUTCOME; VEIN OCCLUSION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEASIBILITY STUDIES; FEMALE; GRAFT OCCLUSION, VASCULAR; HONG KONG; HOSPITAL MORTALITY; HUMANS; MALE; PACLITAXEL; REGISTRIES; SAPHENOUS VEIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 76749168072     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00525.x     Document Type: Article

References (34)

1. FitzGibbon GM, Leach AJ, Kafka HP, et al. Coronary bypass graft fate: Long-term angiographic study. J Am Coll Cardiol 1991 17 : 1075 1080.
2. Weintraub WS, Jones EL, Morris DC, et al. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation 1997 95 : 868 877.
3. Salomon N, Page U, Bigelow J, et al. Reoperative coronary surgery. Comparative analysis of 6591 patients undergoing primary bypass and 508 patients undergoing reoperative coronary artery bypass. J Thorac Cardiovasc Surg 1990 100 : 250 259.
4. Smith SC Jr., Dove JT, Jacobs AK, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 2001 37 : 2215 2239.
5. de Feyter PJ, Serruys P, Van Den Brand M, et al. Percutaneous transluminal angioplasty of a totally occluded venous bypass graft: A challenge that should be resisted. Am J Cardiol 1989 64 : 88 90.
6. Meliga E, García-García HM, Kukreja N, et al. Chronic total occlusion treatment in post-CABG patients: Saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era. Catheter Cardiovasc Interv 2007 70 : 21 25.
7. Hartmann JR, McKeever LS, O'Neill WW, et al. Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts with long-term, low dose direct infusion of urokinase (ROBUST): A serial trial. J Am Coll Cardiol 1996 27 : 60 66.
8. Berger PB, Bell MR, Grill DE, et al. Influence of procedural success on immediate and long-term clinical outcome of patients undergoing percutaneous revascularization of occluded coronary artery bypass vein grafts. J Am Coll Cardiol 1996 28 : 1732 1737.
9. Morice MC, Serruys PW, Sousa JE, et al RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002 346 : 1773 1780.
10. Stone GW, Ellis SG, Cox DA, et al TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004 350 : 221 231.
11. Vermeersch P, Agostoni P, Verheye S, et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: Six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol. 2006 48 : 2423 2431.
12. Thygesen K, Alpert JS, White HD Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007 50 : 2173 2195. (Pubitemid 350123680)
13. Cutlip DE, Windecker S, Mehran R, et al Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007 115 : 2344 2351.
14. Kahn JK, Rutherford BD, McConahay DR, et al. Initial and long-term outcome of 83 patients after balloon angioplasty of totally occluded bypass grafts. J Am Coll Cardiol 1994 23 : 1038 1042.
15. Hoye A, van Domburg RT, Sonnenschein K, et al. Percutaneous coronary intervention for chronic total occlusions: The Thoraxcenter experience 1992-2002. Eur Heart J 2005 26 : 2630 2636.
16. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: A 20-year experience. J Am Coll Cardiol 2001 38 : 409 414.
17. Aziz S, Stables RH, Grayson AD, et al. Percutaneous coronary intervention for chronic total occlusions: Improved survival for patients with successful revascularization compared to a failed procedure. Catheter Cardiovasc Interv 2007 70 : 15 20.
18. Noguchi T, Miyazaki MDS, Morii I, et al. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Determinants of primary success and long-term clinical outcome. Catheter Cardiovasc Interv 2000 49 : 258 264.
19. Puma JA, Sketch MH Jr., Tcheng JE, et al. Percutaneous revascularization of chronic coronary occlusions: An overview. J Am Coll Cardiol 1995 26 : 1 11.
20. Dong S, Smorgick Y, Nahir M, et al. Predictors for successful angioplasty of chronic totally occluded coronary arteries. J Interv Cardiol 2005 18 : 1 7.
21. Stone GW, Rogers C, Hermiller J, et al FilterWire EX Randomized Evaluation Investigators. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003 108 : 548 553.
22. Baim DS, Wahr D, George B, et al Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002 105 : 1285 1290.
23. Mauri L, Cox D, Hermiller J, et al. The PROXIMAL trial: Proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: A randomized, prospective, multicenter clinical trial. J Am Coll Cardiol 2007 50 : 1442 1449.
24. Svilaas T, Vlaar PJ, Van Der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008 358 : 557 567.
25. Sirnes PA, Golf S, Myreng Y, et al. Stenting in Chronic Coronary Occlusion (SICCO): A randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996 28 : 1444 1451.
26. Brodie BR, VerSteeg DS, Brodie MM, et al. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion. Catheter Cardiovasc Interv 2005 65 : 504 509.
27. Kobayashi Y, De Gregorio J, Kobayashi N, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999 34 : 651 659.
28. Oemrawsingh PV, Mintz GS, Schalij MJ, et al TULIP Study. Thrombocyte activity evaluation and effects of ultrasound guidance in long intracoronary stent placement. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: Final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation 2003 107 : 62 67.
29. Tsagalou E, Chieffo A, Iakovou I, et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 2005 45 : 1570 1573.
30. Jim MH, Ho HH, Ko RL, et al. Paclitaxel-eluting stents long-term outcomes in percutaneous saphenous vein graft interventions (PELOPS) study. Am J Cardiol 2009 103 : 199 202.
31. Sianos G, Barlis P, Di Mario C, et al EuroCTO Club. European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club. EuroIntervention 2008 4 : 84 92.
32. Han YL, Wang SL, Jing QM, et al. Percutaneous coronary intervention for chronic total occlusion in 1263 patients: A single-center report. Chin Med J (Engl) 2006 119 : 1165 1170.
33. Migliorini A, Moschi G, Vergara R, et al. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheter Cardiovasc Interv 2006 67 : 344 348. (Pubitemid 43346730)
34. Keeley EC, Velez CA, O'Neill WW, et al. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001 38 : 659 665.